How to Write a Pharmacy Tiering Exception to Lower the Copay - July 2026
How to write a pharmacy tiering exception to lower the copay
If you've ever watched a patient walk away from the pharmacy counter because their medication costs $400 a month when it should cost $40, you know exactly why tiering exceptions matter. They're one of the most underused tools in healthcare advocacy, and most practices aren't writing them as effectively as they could be. With formulary changes hitting mid-year and PBMs tightening their policies through the second half of 2026, this is a good time to sharpen the skill.
---
What is a pharmacy tiering exception?
A tiering exception is a formal request asking a patient's insurance plan to cover a medication at a lower cost-sharing tier than it's currently assigned. Most commercial plans and Medicare Part D plans use a tiered formulary, typically Tier 1 (generics, cheapest) through Tier 4 or 5 (specialty drugs, most expensive). When a drug lands on Tier 3 or higher, the copay can become unaffordable fast.
Plans are legally required to have a tiering exception process. Under the ACA and Medicare Part D regulations, insurers must consider these requests. That doesn't mean automatic approval, but it does mean a correctly written request has a real chance.
Tiering exceptions differ from prior authorizations and from formulary exceptions, which argue that a non-covered drug should be covered at all. A tiering exception assumes the drug is already covered. You're asking the plan to apply a lower tier's cost-sharing. It's a narrower ask, which makes it more winnable.
---
The core elements every strong tiering exception needs
This is where most practices stumble. They submit a vague letter stating the medication is "medically necessary" and stop there. That's not enough. Here's what actually moves the needle:
1. Clinical justification tied to the specific patient
Don't just describe the drug. Describe why this patient, at this moment, needs this drug at this cost. Reference their diagnosis, relevant comorbidities, how long they've been on the medication, and how they've responded. If they've been stable on a Tier 3 branded medication for two years, say that. Stability is a clinical argument.
2. Documentation of alternatives tried (or why they're not appropriate)
Most plans want to see that cheaper alternatives were considered. Either the patient tried them and they failed (side effects, inadequate response, contraindication) or there's a clinical reason those alternatives don't apply. Be specific. "Patient tried metformin and experienced significant GI intolerance requiring discontinuation after six weeks" carries far more weight than "alternatives were tried."
3. A cost-and-access argument
This one gets overlooked. If the current copay creates financial hardship likely to cause the patient to abandon therapy, say so. Medication non-adherence has real clinical consequences: hospitalizations, disease progression, ER visits. You're allowed to connect those dots in your letter. Plans understand that a $400 copay often means a $0 medication because the patient simply doesn't fill it.
4. The specific request
Be explicit. State clearly: "We are requesting a tiering exception to cover [Drug Name] at the Tier [X] cost-sharing level." Don't leave the reviewer guessing what you're asking for.
---
Common mistakes that sink tiering exception requests
- Generic templates with no patient-specific detail. Payers see these constantly. If it reads like a form letter, it gets treated like one.
- Missing provider credentials or NPI. Sounds basic, but it happens regularly. Missing information is an easy reason to delay or deny.
- Not addressing the plan's own formulary language. Some PBMs publish specific tiering exception criteria in their formulary guidelines. If you can reference those criteria and show your patient meets them, you're speaking the reviewer's language.
- Submitting without supporting clinical records. A letter alone often isn't enough. Attach relevant chart notes, lab results, or prior treatment records. More documentation gives the reviewer what they need to approve the request.
- Waiting too long. If a patient's plan year reset in July 2026 and their formulary changed, there's often a limited window, frequently 60 days, to appeal mid-year formulary transitions without starting over.
---
The submission process
The clinical argument is only half the work. Submission mechanics matter too.
Start by checking the plan's specific tiering exception requirements, which vary by payer. Some require the prescribing physician to submit; others accept requests from the practice or a billing manager acting on the patient's behalf with an assignment of benefits on file. Medicare Part D exceptions must be submitted by the enrollee, their representative, or the prescriber.
Quick process checklist:
- Confirm the drug's current tier and what tier you're requesting
- Get the plan's tiering exception form (many have their own; others accept a letter)
- Verify the submission fax number or portal, because these change more often than they should
- Set a follow-up reminder at 72 hours for urgent requests, 14 days for standard
- If denied, request a written denial with the specific reason stated. You'll need it for the appeal.
Turnaround times for standard requests are typically 72 hours under Medicare and 15 days commercially. Expedited requests, warranted when a standard timeline could seriously jeopardize the patient's health, should be processed within 24 hours. Flag urgency when it's real.
---
Using technology to speed up the process
Writing individualized, clinically grounded tiering exceptions takes time, and most practices don't have much of it. AI-powered appeal and exception generators are starting to help in this space. These tools can pull patient-specific data and produce a customized draft in a fraction of the time it takes to write from scratch, leaving the clinician to review and sign off rather than stare at a blank page.
No tool replaces clinical judgment, though. Whatever produces the initial draft, a clinician still needs to confirm that the clinical narrative actually reflects the patient's situation. A polished letter built on the wrong clinical story can create problems if a reviewer starts asking follow-up questions.
---
Where to focus next
Tiering exceptions work more often than people expect when they're written well. The difference almost always comes down to specificity: specific patient, specific clinical history, specific request. Plans aren't hunting for a reason to say no. Their reviewers need documentation that gives them cover to say yes.
If your practice isn't tracking tiering exception outcomes yet, start a simple log now. Record submissions, approvals, denials, and denial reasons. Patterns show up quickly: which plans approve most readily, which arguments land, and where patient access is slipping through the cracks.
A few concrete starting points:
- Pull your most common high-tier medications and identify which patients might benefit from a tiering exception request
- Review the formularies for your top payers to understand what the tier structure looks like mid-2026
- Build a simple intake flag so anyone on the team can identify a tiering exception need before it gets missed
- Draft a master template with the core structure, then customize it every single time
See EZAppeal work on a real denial
It drafts appeals and prior authorizations grounded in the payer's own published policy. BAA included, zero PHI stored. Try the live demo, no signup →